AbuDhabiPR.com, Online Press Release from Abu Dhabi and Al Ain
 
Events and Exhibitions(Events & Exhibitions)
Filter PR by
  
Khaled bin Mohamed bin Zayed Chairs Emirates Genome Council Meeting
 
His Highness reviewed progress on precision medicine initiatives and endorsed prioritised R&D plans 
 
• R&D plans have been set in line with public health priorities to integrate precision medicine and accelerate solutions for prevention and treatment of genetic disorders
• 41 IRB-approved studies to be carried out in areas covering most prevalent genetic disorders in the UAE including cancer and cardio-metabolic conditions
• Emirati Genome Program achieves 500,000 samples milestone, and further organisational collaborations are encouraged to achieve one million samples target 
 
Abu Dhabi, 9 November 2023: His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, has chaired the meeting of the Emirates Genome Council.
 
During the meeting, they reviewed progress on precision medicine initiatives and R&D priorities aimed at accelerating solutions for the prevention and treatment of genetic disorders.
 
His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, at the start of the meeting, emphasised that the leadership is committed to enhancing the community’s wellbeing.  His Highness also highlighted the importance of focusing on precision medicine initiatives to further enhance public health in the UAE and reinforce the country’s position at the forefront of global genomic research and innovation.
 
R&D priorities
 
His Highness reviewed the prioritised R&D areas identified by the council’s Genomics Research Committee, which focus on public health priorities in the UAE. The agenda aims to optimise the utilisation of genomics in precision medicine programs that will improve early detection of the most common genetic health conditions, in addition to enabling personalised treatment approaches that prioritise patient outcomes and enhance quality of life. The findings will also inform public health policies and support sustainable public health strategies.
 
So far, 41 studies approved by the UAE’s Institutional Review Boards (IRB) are underway, covering the most prevalent genetic diseases including cancer and cardio-metabolic conditions which account for the top two causes of mortality in the UAE. These include breast, colorectal and thyroid cancers; coronary artery disease; and diabetes mellitus among others.
 
Her Excellency Sarah bint Yousef Al Amiri, Secretary General of the Emirates Genome Council said: “Establishing priorities for genomic R&D is essential for the integration of effective precision medicine programmes. This will accelerate the introduction of solutions tailored to public health priorities and will have a significant impact on the community.
 
“Focusing on key public health areas will allow us to develop long-term solutions that reduce the prevalence and severity of commonly occurring conditions and have a lasting impact on the health and wellbeing of our community. Additionally, aligning research efforts with public health priorities will lead to more optimal collaborations between researchers, clinicians, and healthcare technology providers, and will fast-track delivery of truly personalised, precise and effective healthcare programmes.”
 
Precision medicine programme updates
 
His Highness reviewed updates on pilot precision medicine programmes, which are linked to the R&D priority areas, in addition to recommendations on new clinical studies that could further the utilisation of genomics within the UAE’s healthcare ecosystem. These include genetic disease prevention programmes that will accurately identify and predict disorders and enable preventive care, in addition to diagnosis programmes that support personalised treatments. 
 
Significant genetic disease prevention programmes include the expansion of genetic pre-marital screening to cover 570 medical conditions. The programme, which was piloted by the Department of Health – Abu Dhabi in November 2022, is currently available at 19 medical clinics in the capital, with plans to pilot the program across the UAE. Plans are also in place to introduce newborn and targeted gene panel screenings. 
 
Genetic disease diagnosis programmes piloted include the region’s first breast cancer precision medicine programme, and a programme to support critically ill children in ICUs, with plans in place to launch programmes that focus on diabetes among other common genetic conditions.   
Plans underway also include pharmacogenomics (PGx) programmes which are critical to supporting effective medication regimens and avoiding adverse effects for several major conditions.
 
Emirati Genome Program progress
 
The Emirati Genome Program (EGP), one of the largest population genomic initiatives in the world, has now reached a key milestone of 500,000 samples collected at 102 active sites across the nation. More than 400 schools in Abu Dhabi are taking part in the EGP, with plans to expand the opportunity for schools to participate nationwide.
 
The EGP is a significant project under the National Genome Strategy and will support the transformation of healthcare services in the UAE by providing high-quality genetic data that allows researchers, physicians, and scientists to identify the causes of genetic diseases, understand the type of genetic mutations, anticipate susceptibility to some diseases, and develop effective personalised healthcare plans. The initiative aims to collect 1 million samples, and the council has directed further collaborations be pursued to meet the national target. 
 
The programme is implemented in collaboration with G42 Healthcare and is coordinated with healthcare regulators including the Ministry of Health and Prevention (MoHAP), Emirates Health Services Establishment, the Department of Health – Abu Dhabi, the Dubai Health Authority and Dubai Academic Health Corporation, as well as academic, medical and other institutions extending their support to the program.
 
The meeting was attended by H.E. Mohammed Abdullah Al Gergawi, UAE Minister of Cabinet Affairs and Chairman of the Federal Competitiveness and Statistics Authority; H.E. Abdul Rahman Mohammed Al Owais, UAE Minister of Health and Prevention; H.E. Omar Sultan Al Olama, UAE Minister of State for Artificial Intelligence, Digital Economy and Remote Work Applications; H.E. Mansour Ibrahim Al Mansouri, Chairman of the Department of Health – Abu Dhabi; H.E. Awad Sagheer Al Ketbi, Director-General of the of Dubai Health Authority (DHA); H.E. Dr. Amer Ahmed Al-Sharif, the CEO of Dubai Academic Health Corporation and President of Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU); Professor Dr. Eric Xing, University Professor and President of the Mohamed bin Zayed University of Artificial Intelligence (MBZUAI); H.E. Dr. Yousif Mohammed Al-Serkal, Director-General of Emirates Health Services (EHS); and Fatima Sultan Al Zaabi, Director of the Department of Biodiversity at the Environment and Protected Areas Authority in Sharjah.

Posted by : Abu Dhabi and Al Ain PR Network Editorial Team
Viewed 301 times
PR Category : Events & Exhibitions
Posted on : Friday, November 10, 2023  11:43:00 AM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AbuDhabiPR.com.
Previous Story : Abu Dhabi International Boat Show 2023 Takes to the Water
Next Story : Dubai Gears Up for the Debut Japan Kyoto Trade Exhibition
Email this article Print this article

Share this article with your friends and followers
NewsVine
Back to Section Home

Related Stories



 
 
Most Viewed Press Release posted in the last 7 days
Preventing Famine and Deadly Disease Outbreaks in Gaza Requires Faster, Safer Aid access and more Su... [22434-Views]
Catrice celebrates Valentine's Day with a timeless twist: Recreate the Old Money Look using our ex... [14931-Views]
The Dyson AirstraitTM Straightener Soon to Arrive in the UAE and KSA! [14610-Views]
EASA Partners with IATA to Counter Aviation Safety threat from GNSS Spoofing and Jamming [14212-Views]
Air Cargo Demand Surges 10.8% in December, Closing 2023 Near 2022 Levels [14188-Views]
Winners Revealed for “TRT World Citizen Awards” [14008-Views]
The Dyson AirstraitTM straightener now available in the UAE! [13106-Views]
Tata Soulfull Launches in UAE and Kuwait [12893-Views]
Oman's Smart Vision Summit Gains Momentum with XS.com as Global Sponsor [12447-Views]
Saudi Star Yara Alhogbani Confirmed for Mubadala Abu Dhabi Open [10610-Views]
International Pro Wrestling Championship 2024 to witness Indian and Pak wrestling heroes facing off [10072-Views]
STATEMENT BY PRINCIPALS OF THE INTER-AGENCY STANDING COMMITTEE - CIVILIANS IN GAZA IN EXTREME PERIL ... [9102-Views]
IATA and The Weather Company Collaborate to Provide Enhanced Turbulence-Related Weather Data to Airl... [8912-Views]
Milrem Robotics Showcases Their Most Advanced Robotic Vehicles at the World Defense Show in Riyadh [8451-Views]
MKB Bespoke Audio unveils the Middle East's first-of-its kind Experience Centre for premium audio-vi... [7999-Views]
Xiaomi Introduces All-new Redmi Note 13 Line-up [6196-Views]
Tabreed Achieves Significant Energy Savings with Variable Frequency Drives in Extensive Retrofit Pro... [6187-Views]
2023 Safest Year for Flying By Several Parameters [6116-Views]
SEHA Hosts 4th Abu Dhabi Integrated Mental Health Conference with International Experts [5763-Views]
ADU's College of Engineering Hosts the First RoboCar Maze Competition in its Al Ain Campus [5601-Views]
 
RSS Facebook Twitter LinkedDin AbuDhabiPR.com on Instagram
 
Top Sections
 
Top Stories